Ad Acqui Terme, il 15 e 16 settembre, si terrà il 14° Meeting annuale del Gruppo di Lavoro di Progetto Mielina.

Il Presidente Augusto Odone darà il benvenuto ai ricercatori provenienti da varie parti del mondo per discutere di vari temi riguardanti le malattie demielinizzanti.

Qui sotto l'agenda dei lavori del meeting.

14th Annual Meeting of The Myelin Project Work Group
September 15-16, 2003
Acqui Terme, Italy

AGENDA

Monday, September 15

9:00-9:15 a.m. Welcoming Address
Augusto Odone, Myelin Project President
Dr. Ian Duncan, Meeting Chairman

Focus I: Transplantation

9:15-9:45 a.m. Neural stem cell transplantation in MS: From mice to marmosets-implications (and plans) for prospective human trials in MS
Gianvito Martino, San Raffaele Scientific Institute

9:45-10:15 a.m. Schwann cell transplantation in the macaque model of MS-implications (and plans) for prospective human trials in MS
Anne Baron-Van Evercooren and Bertrand Fontaine, Salpêtrière Hospital

10:15-10:45 a.m. Schwann cell transplantation redux: Plans for a second clinical trial
Timothy Vollmer, Barrow Neurological Institute

10:45-11:00 a.m. Coffee break

11:00-11:30 a.m. Intraventricular transplantation: Cell diffusion, differentiation, and remyelination
Ian Duncan, University of Wisconsin-Madison

11:30 a.m.-12:00 p.m. Factors that influence transplant-mediated remyelination
William Blakemore, Cambridge University

12:00-12:30 p.m. General discussion

12:30-1:00 p.m. Interaction between families and researchers: Q & A session

Focus II: Prospects for Cell-Based Therapies

2:00-2:30 p.m. Bone marrow stromal cells as a potential cell source for glial and neural repair Jeffery Kocsis, Yale University

2:30-3:00 p.m. The role of embryonic stem cells in the repair of the damaged CNS
John McDonald, Washington University in St. Louis

3:00-3:30 p.m. Derivation of transplantable oligodendrocyte precursors from embryonic stem cells
Su-Chun Zhang, University of Wisconsin-Madison

3:30-4:00 p.m. Development and maintenance of neural stem cell lines
Angelo Vescovi, San Raffaele Institute for Stem Cell Research

4:00-4:15 p.m. Afternoon break

4:15-5:15 p.m. Panel discussion: Current state of stem cell research and prospects for clinical applications
Angelo Vescovi, Evan Snyder, Su-Chun Zhang, John McDonald, Jeffery Kocsis Note: All researchers are invited to participate

5:15-5:45 p.m. Interaction between families and researchers: Q & A session

Tuesday, September 16

Focus III: Pharmacological Substances

9:00-9:30 a.m. Simvastatin for MS: Clinical trial report
Inderjit Singh, Medical University of South Carolina, and Timothy Vollmer, Barrow Neurological Institute

9:30-10:00 a.m. Prospective trial of progestin in post-partum women with MS
Etienne-Emile Baulieu, Michael Schumacher, and Martine El-Etr, Bicêtre Hospital; Christian Confavreux, Hopital Neurologique

Focus IV: Individual Myelin Diseases

10:00-10:30 a.m. Follow-up of the international study of the preventive efficacy of Lorenzo's Oil in adrenoleukodystrophy
Hugo Moser, Kennedy Krieger Institute

10:30-11:00 a.m. Clinical trial of Lorenzo's Oil in adrenomyeloneuropathy: Results and follow-up
Wolfgang Koehler, Saxonian State Hospital Hubertusburg

11:15-11:45 a.m. Umbilical cord blood stem cell transplantation in the leukodystrophies
Joanne Kurtzberg, Duke University, and Maria Escolar, University of North Carolina at Chapel Hill

11:45 a.m.-12:15 p.m. General discussion

12:15-12:45 p.m. Interaction between families and researchers: Q & A session

2:00-2:30 p.m. Clinical trial of gene therapy in children with Canavan disease
Paola Leone, Robert Wood Johnson Medical School

2:30-3:00 p.m. Discovering the gene underlying sulfatase deficiencies and implications for metachromatic leukodystrophy
Andrea Ballabio, Telethon Institute of Genetics and Medicine

3:00-3:30 p.m. Gene therapy applications for metachromatic leukodystrophy and other diseases
Claudio Bordignon, San Raffaele Scientific Institute

3:30-4:00 p.m. Update on gene therapy for MS and other myelin diseases
Fulvio Mavilio, San Raffaele Scientific Institute

4:00-4:15 p.m. Afternoon break

4:15-4:45 p.m. General discussion

4:45-5:15 p.m. Interaction between families and researchers: Q & A session